Exploration Science with Dr. Wendy Harsock

Within the framework of the discussion-based interview series, Exploration Science, in which scientists talk about their ventures and areas of expertise, our CEO, Dr. Meritxell Teixidó, and the first and only APS American Peptide Idol joined @CEM's Dr. Wendy Hartsock to discuss the work @Gate2Brain is doing in pediatric oncology, dive into the technology, and talk about empathetic leadership and the power of diversity.CEM

Within the framework of the discussion-based interview series, Exploration Science, in which scientists talk about their ventures and areas of expertise, our CEO, Dr. Meritxell Teixidó, and the first and only APS American Peptide Idol joined CEM‘s Dr. Wendy Hartsock to discuss the work Gate2Brain is doing in pediatric oncology, dive into the technology, and talk about empathetic leadership and the power of diversity.

Because collaborations and connections are the ones that make the difference!!!

Listen to the podcast

 

/by
You might also like
Meritxell Teixidó (Gate2Brain, Medicines Beyond Barriers): “Utilitzem una nova tecnologia basada en pèptids per millorar el transport de fàrmacs al cervell”Meritxell Teixidó (Gate2Brain, Medicines Beyond Barriers): “We use a new technology based on peptides to improve the transport of drugs to the brain”
Three University of Barcelona spin-offs led by women will receive funding as part of the Women TechEU pilot callFundació Bosch i GimperaThree University of Barcelona spin-offs will receive funding from Women TechEU pilot call
Gate2Brain abre una ronda puenteo de un millón de euros para ensayos preclínicoPlantaDoceGate2Brain opens one million euro bridge round for preclinical trials
Gate2Brain at TransfiereG2BG2B at Transfiere 2023
GATE2BRAIN winner of the Barcelona Activa Pre-acceleration competitionBarcelona ActivaGATE2BRAIN WINNER OF THE BARCELONA ACTIVA PRE-ACCELERATION COMPETITION
Sustainability Policies, Innovation, Entrepreneurship and New Production Models.g2bSustainability Policies, Innovation, Entrepreneurship and New Production Models
Technology closer to young patientsG2BTechnology closer to young patients
¿Cómo transportar fármacos al cerebro para tratar patologías?La VanguardiaHow to transport drugs to the brain to treat pathologies?
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

A technology to help treat pediatric cancerUna tecnología para ayudar a tratar el cáncer infantilgate2brainEITHealth Catapult 2022eithealthGate2Brain semifinalist of EITHealth’s Catapult 2022